Stem Cell Exosomes:
The Messengers Behind MSC Therapy
Exosomes are the tiny delivery vehicles that carry MSC therapy’s therapeutic cargo — proteins, growth factors, and microRNA — directly to damaged tissue. They’re not stem cells. They’re what makes stem cells work. Here’s the science.
In This Guide
For years, scientists assumed that stem cell therapy worked because transplanted cells became new tissue. The reality is more nuanced — and more interesting. Research now shows that much of MSC therapy’s therapeutic effect comes not from the cells themselves, but from what they secrete: tiny vesicles called exosomes.
Exosomes are the communication system of regenerative medicine — nanoscale packages that carry anti-inflammatory signals, growth factors, and genetic instructions from stem cells to damaged tissue. Understanding exosomes is understanding how stem cell therapy actually works at the molecular level.
What Are Exosomes?
Exosomes are extracellular vesicles — tiny membrane-bound packages ranging from 30 to 150 nanometers in diameter (roughly 1/1000th the size of a human cell). They are naturally released by virtually all cell types, but MSC-derived exosomes are of particular therapeutic interest because they carry the same regenerative cargo that makes MSC therapy effective.
First identified in the 1980s and initially dismissed as cellular waste products, exosomes were recognized by the mid-2000s as a sophisticated cell-to-cell communication system. When an MSC releases exosomes, those vesicles travel through the bloodstream or local tissue, fuse with target cells, and deliver their cargo — effectively reprogramming the recipient cell’s behavior without the MSC needing to be physically present.
This discovery fundamentally changed our understanding of how stem cell therapy works. It suggested that the cells themselves might be less important than what they release — and opened the door to acellular regenerative therapies that deliver the therapeutic cargo without transplanting living cells.
The Analogy: If MSCs are factories, exosomes are the delivery trucks. The factory produces the goods (anti-inflammatory proteins, growth factors, microRNA), packages them into trucks (exosomes), and ships them to where they’re needed (damaged tissue). Exosome therapy delivers the trucks directly — skipping the factory entirely.
What’s Inside an Exosome
Each exosome carries a complex cargo of bioactive molecules derived from the parent MSC.
1,000+ Bioactive Proteins
Anti-inflammatory cytokines (IL-10, TGF-β), growth factors (VEGF, HGF, IGF-1), and signaling molecules that suppress inflammation, promote tissue repair, and modulate immune responses. The protein profile mirrors the MSC’s paracrine secretome.
Regulatory microRNA (miRNA)
Small non-coding RNA molecules that silence specific genes in target cells. MSC exosome miRNAs can downregulate inflammatory gene expression, promote cell survival, and shift immune cell behavior — effectively reprogramming recipient cells at the genetic level.
mRNA Transcripts
Functional messenger RNA that can be translated into proteins by recipient cells. This means exosomes don’t just deliver proteins — they deliver the instructions for making new ones, extending their therapeutic influence beyond the initial cargo.
Bioactive Lipid Mediators
The exosome membrane itself is composed of lipids (sphingomyelin, cholesterol, ceramides) that have biological activity. These lipid components contribute to anti-inflammatory signaling and help the exosome fuse with target cell membranes for cargo delivery.
How Exosomes Deliver Therapy
Exosomes use multiple pathways to influence target cells and promote tissue repair.
Surface Receptor Binding
Exosome surface proteins bind to receptors on target cells, triggering signaling cascades that reduce inflammation and promote repair — without the exosome needing to enter the cell.
Membrane Fusion
Exosomes fuse directly with the target cell membrane, releasing their entire cargo (proteins, RNA, lipids) into the cytoplasm. This delivers a concentrated therapeutic payload in a single event.
Endocytosis
Target cells actively engulf exosomes through endocytosis — pulling them inside where cargo is released intracellularly. This is the most common uptake pathway for MSC-derived exosomes.
Gene Regulation
Once inside, exosomal miRNA silences pro-inflammatory genes and upregulates repair genes in the recipient cell — changing its behavior from inflammatory to regenerative at the genetic level.
Immune Modulation
MSC exosomes shift macrophages from M1 (pro-inflammatory) to M2 (anti-inflammatory) phenotype, suppress overactive T-cells, and promote regulatory T-cell formation — mirroring the immunomodulatory effect of live MSCs.
Tissue Repair Support
Exosomal growth factors promote angiogenesis (new blood vessel formation), recruit local progenitor cells, and inhibit apoptosis (cell death) — creating a regenerative microenvironment around the treatment site.
Exosomes vs. Live Stem Cells
Understanding the difference is critical for making an informed treatment decision.
| Feature | Live MSC Therapy | Exosome Therapy |
|---|---|---|
| What Is It | Living cells transplanted into patient | Cell-free vesicles delivered to patient |
| Contains Living Cells | ✔ Yes — 40M MSCs | ✗ No — acellular |
| Mechanism | Cells engraft, secrete factors over time | One-time cargo delivery to target cells |
| Duration of Action | Sustained — cells active for weeks/months | Shorter — cargo delivered at once |
| Tumor Risk | Very low (MSCs don’t form tumors) | Zero — no cells, no replication |
| Immune Rejection Risk | Very low (immunoprivileged) | Negligible — no HLA antigens |
| Storage | Requires cryo-preservation | More stable — can be lyophilized |
| Clinical Evidence | Extensive — 1,700+ trials | Growing — earlier stage |
| Standardization | Some variability per batch | Easier to standardize |
| Best For | Comprehensive regenerative therapy | Targeted anti-inflammatory support |
Our Perspective: Exosomes and live MSC therapy are not competitors — they’re complementary. Live MSCs act as ongoing factories that produce exosomes (and many other therapeutic factors) for weeks after transplant. Exosomes deliver a concentrated, one-time dose. Which is right depends on your condition, goals, and where you are in your treatment journey. We discuss both options during consultation.
Why MSC-Derived Exosomes Specifically
All cells produce exosomes, but the cargo inside depends entirely on the parent cell. Cancer cell exosomes promote tumor growth. Immune cell exosomes modulate immune responses. MSC-derived exosomes carry the anti-inflammatory, immunomodulatory, and pro-regenerative cargo that makes MSC therapy therapeutically valuable.
Research has shown that MSC exosomes replicate many of the beneficial effects of live MSC therapy. A landmark 2017 study by Phinney & Pittenger in Stem Cells demonstrated that MSC exosomes could reproduce the immunomodulatory effects of their parent cells — suppressing T-cell proliferation, shifting macrophage polarization, and reducing inflammatory cytokine production.
The source of the parent MSC matters too. Exosomes from Wharton’s Jelly MSCs carry a more potent anti-inflammatory and regenerative payload than exosomes from older, adult-derived MSCs — because the parent cells are younger, more active, and secrete a richer paracrine profile. This is why the tissue source hierarchy (Wharton’s Jelly > bone marrow > adipose) applies to exosomes as well.
What MSC Exosomes Have Been Shown to Do
In preclinical research, MSC-derived exosomes have demonstrated the ability to reduce inflammatory markers in joint tissue, promote cartilage cell (chondrocyte) survival, accelerate tendon healing, improve wound closure rates, reduce fibrosis in organ tissue, and modulate immune responses in autoimmune models. Clinical trials are underway but remain in earlier stages than live MSC therapy.
Important Nuance: The exosome field is exciting but early. While preclinical evidence is strong, large-scale human clinical trial data for MSC exosomes is still limited compared to the 1,700+ trials for live MSC therapy. We present the science honestly and help patients understand where the evidence stands for each approach.
Where Exosome Therapy Is Being Studied
Research into MSC-derived exosomes spans musculoskeletal, dermatological, and systemic conditions.
Osteoarthritis
Cartilage protection & inflammationJoint Pain
Anti-inflammatory signalingTendon Injuries
Healing accelerationSkin Rejuvenation
Collagen & elastin signalingWound Healing
Tissue repair & angiogenesisSystemic Inflammation
Immune modulationNeurological (Research)
Neuroprotection studiesCardiovascular (Research)
Cardiac repair studiesPulmonary (Research)
Fibrosis & inflammation studiesKey Studies in Exosome Science
A selection of significant publications shaping the field of MSC-derived exosome therapy.
A Word of Caution About the Exosome Market
We believe in transparency — and the exosome market requires some honest conversation.
The hype problem. Exosomes have become one of the most marketed terms in regenerative medicine. Some clinics sell “exosome therapy” as a miracle product without explaining what’s actually in the vial, where it came from, or whether it contains verified, functional exosomes. The FDA has issued warnings to companies making unsubstantiated claims about exosome products.
The quality problem. Not all exosome products are equal. Some commercial “exosome” products contain very few actual exosomes — they may be conditioned media (the liquid MSCs grew in) with minimal vesicle content. Without rigorous characterization (particle count, size distribution, protein markers, RNA profiling), it’s impossible to know what you’re getting.
The evidence gap. While preclinical data is promising, large-scale randomized controlled trials for MSC exosome therapy are still in early stages. The clinical evidence base for exosomes is significantly smaller than for live MSC therapy. Any clinic claiming exosomes are “proven” is overstating the current science.
Our Position: We offer exosome therapy as part of our regenerative protocols — but we don’t overpromise. We use verified, MSC-derived exosome products from reputable sources and are transparent about what the science does and doesn’t support. If live MSC therapy is better for your situation, we’ll tell you. If exosomes make more sense, we’ll explain why. The goal is the right treatment, not the trendiest one.
How We Use Exosomes at The Stem Cell Club
Exosomes at The Stem Cell Club are positioned as a complement to our core live MSC therapy — not a replacement. Here’s how we approach it:
Combination protocols. For some patients, combining live WJ-MSC therapy with exosome therapy creates a more comprehensive treatment. The live cells provide sustained, ongoing paracrine signaling for weeks to months, while exosomes deliver an immediate, concentrated dose of therapeutic cargo.
Targeted applications. Exosomes may be particularly useful for localized conditions — joint injections, soft tissue support, and dermatological applications — where a concentrated, acellular treatment can be applied directly to the problem site.
Honest recommendations. During your consultation, we’ll discuss whether exosomes, live MSC therapy, or a combination makes the most sense for your condition. We don’t push exosomes as an add-on to inflate your bill — if live MSC therapy alone is the best approach, that’s what we’ll recommend.
Quality sourcing. Our exosome products are MSC-derived, from verified sources, with documented characterization. We don’t use unverified “exosome” products of unknown composition.
Exosome Therapy FAQ
Curious Whether Exosome Therapy Is Right for You?
Schedule a free consultation. We’ll explain the science honestly, discuss whether exosomes, live MSC therapy, or a combination makes sense for your situation — and give you clear pricing upfront.
Related Resources
Exosomes + MSCs. Science, Not Hype.
We offer exosome therapy as part of our regenerative protocols — not as a magic bullet. Honest science, verified products, physician-guided recommendations. The right treatment for your situation, at a fair price.
Disclaimer: Exosome therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. All clinical references on this page are based on published, peer-reviewed research. This content is provided for educational purposes only and does not constitute medical advice. Individual results vary. A consultation with our medical team is required to determine treatment appropriateness.
MSC Stem Cells:
The Complete Guide
Mesenchymal stem cells are the most widely studied cell type in regenerative medicine — backed by thousands of clinical trials worldwide. We deliver 40 million premium umbilical cord MSCs for $1,999. Here’s why that matters.
In This Guide
Mesenchymal stem cells — commonly called MSCs — are the workhorse of modern regenerative medicine. First isolated from bone marrow in the 1970s, they’ve since become the most widely studied stem cell type in human clinical trials, with over 1,700 registered studies on ClinicalTrials.gov.
What makes MSCs valuable isn’t just what they become — it’s what they do. MSCs secrete a powerful cocktail of anti-inflammatory cytokines, growth factors, and signaling molecules that can modulate the immune system, reduce chronic inflammation, and support tissue repair. This paracrine activity is now considered their primary therapeutic mechanism.
What Are Mesenchymal Stem Cells?
MSCs are multipotent adult stem cells — meaning they can differentiate into several related cell types, including bone (osteocytes), cartilage (chondrocytes), fat (adipocytes), and muscle cells. They were first described by Alexander Friedenstein in the 1970s and formally named by Arnold Caplan in 1991.
The International Society for Cellular Therapy (ISCT) defines MSCs by three minimum criteria: they must adhere to plastic in standard culture conditions, express specific surface markers (CD73, CD90, CD105) while lacking others (CD45, CD34, CD14, CD11b, CD79α, CD19, HLA-DR), and demonstrate the ability to differentiate into osteoblasts, adipocytes, and chondroblasts in vitro.
But in clinical practice, the most important thing MSCs do isn’t differentiate — it’s communicate. Through paracrine signaling, MSCs release hundreds of bioactive molecules that suppress inflammation, recruit local repair cells, inhibit cell death, promote new blood vessel formation, and modulate immune responses. This is why a single IV infusion can have systemic effects across multiple organ systems.
Key Insight: While MSCs can become bone, cartilage, and fat cells, their primary therapeutic value comes from paracrine signaling — the release of anti-inflammatory cytokines, growth factors, and extracellular vesicles that modulate immune function and support tissue repair throughout the body. Think of them less as replacement parts and more as biological repair coordinators.
Where MSCs Come From
MSCs exist naturally throughout the human body. They can be harvested from multiple tissue sources, each with distinct advantages and limitations:
Bone Marrow — The original source. Harvested via aspiration from the iliac crest (hip bone). Well-studied, but the procedure is invasive and painful. MSC quantity and quality decline significantly with age — a 60-year-old’s bone marrow contains a fraction of the MSCs found in a 20-year-old’s.
Adipose (Fat) Tissue — Harvested via liposuction. Abundant source, but MSCs have higher donor variability and require more processing. Fat-derived MSCs have a different cytokine profile than bone marrow or umbilical cord MSCs.
Umbilical Cord Tissue (Wharton’s Jelly) — Harvested from donated umbilical cord tissue after healthy births. These are the youngest, most potent MSCs available — with the longest telomeres, highest proliferative capacity, and strongest immunomodulatory properties. No invasive harvest procedure is required for the patient. This is what we use.
Peripheral Blood, Dental Pulp, Placenta — Additional sources under research, but less established for clinical therapy.
Why Source Matters: The tissue source determines everything — cell potency, proliferative capacity, immunomodulatory strength, and patient safety. Younger cells perform better. Umbilical cord MSCs are harvested at birth, making them the youngest and most biologically active source available for allogeneic (donor-based) therapy.
How MSC Therapy Works
MSCs operate through four primary mechanisms that work together to reduce inflammation and support repair.
Anti-Inflammatory Signaling
MSCs secrete anti-inflammatory cytokines (IL-10, TGF-β, PGE2) that suppress chronic inflammatory pathways. This is their most well-documented therapeutic mechanism — reducing the chronic inflammation that drives joint degeneration, back pain, and systemic conditions.
Immunomodulation
MSCs regulate both innate and adaptive immune responses — suppressing overactive T-cells, promoting regulatory T-cells, and shifting macrophages from pro-inflammatory (M1) to anti-inflammatory (M2) states. This makes them relevant for autoimmune conditions and chronic inflammatory diseases.
Trophic Support
Through growth factors (VEGF, HGF, IGF-1, bFGF), MSCs promote new blood vessel formation (angiogenesis), stimulate local progenitor cells, and inhibit cell death (apoptosis). They create a regenerative microenvironment that supports the body’s own healing processes.
Extracellular Vesicle Secretion
MSCs release exosomes and microvesicles packed with proteins, lipids, and microRNA that influence nearby cells. Research increasingly suggests that these vesicles — not the MSCs themselves — may mediate many of the observed therapeutic effects, extending the cells’ influence far beyond their immediate location.
Why We Use Umbilical Cord MSCs
Not all MSCs are equal. The tissue source dramatically affects potency, safety, and therapeutic outcomes.
We use MSCs derived from Wharton’s Jelly — the connective tissue matrix within the human umbilical cord. Here’s why this matters:
Youngest available cells. Harvested at birth, umbilical cord MSCs have the longest telomeres and highest proliferative capacity of any MSC source. Bone marrow MSCs from a 50-year-old have been through decades of cellular aging — umbilical cord MSCs haven’t.
Strongest immunomodulatory profile. UC-MSCs express low levels of HLA class II antigens and high levels of immunosuppressive factors, making them less likely to trigger immune rejection than bone marrow or adipose MSCs. This enables safe allogeneic (donor-based) therapy.
No invasive harvest. The patient doesn’t undergo bone marrow aspiration (painful hip drilling) or liposuction. Umbilical cord tissue is collected after healthy births from consenting donors — a process that’s painless for both mother and child.
Consistent quality. Bone marrow and adipose MSC quality varies enormously based on the patient’s age, health, and genetics. Umbilical cord MSCs from screened, healthy donors provide a consistent, high-potency product every time.
Ethically uncontroversial. Umbilical cord tissue is typically discarded after birth. Using it for stem cell therapy gives this tissue a second purpose with no ethical concerns.
MSC Source Comparison
How umbilical cord MSCs compare to bone marrow and adipose-derived alternatives.
| Feature | Bone Marrow MSCs | Adipose MSCs | Umbilical Cord MSCs |
|---|---|---|---|
| Cell Age | Patient’s age (older) | Patient’s age (older) | ✔ Neonatal (youngest) |
| Proliferative Capacity | Moderate — declines with age | Moderate | Highest — longest telomeres |
| Immunomodulatory Strength | Moderate | Moderate | Strong — low HLA-II, high suppression |
| Harvest Method | Invasive — iliac crest aspiration | Invasive — liposuction | Non-invasive — donated tissue |
| Donor Variability | High — age/health dependent | High — variable quality | Low — screened, consistent |
| Immune Rejection Risk | Low (autologous) | Low (autologous) | Low — immunoprivileged |
| Ethical Concerns | None | None | None — otherwise discarded |
| Clinical Evidence | Extensive | Moderate | Extensive and growing |
What You’re Getting at The Stem Cell Club
Not all clinics are transparent about what’s in their stem cell product. We are.
U.S.-Sourced Only
100% American umbilical cord tissue from FDA-registered labs. No offshore labs, no unknown supply chains.
Screened Donors
Carefully screened donor mothers with full medical history review. Non-vaccinated donors per patient preference.
Lab-Verified Potency
Third-party testing confirms cell count and viability before treatment. You know exactly what you’re receiving.
FDA Compliant
Minimally manipulated per all FDA guidelines for human cells, tissues, and cellular and tissue-based products (HCT/P).
Proper Cold Chain
Cryo-preserved at optimal temperature. Temperature monitored throughout the entire supply chain from lab to clinic.
Physician-Administered
Andrea Montana, MSN, APRN oversees every treatment. No unsupervised techs. No rushed procedures.
Why We Source Direct: Many stem cell clinics buy from brokers who buy from labs — each adding a markup. We source directly from FDA-registered laboratories, eliminating middleman costs. Same cells, same quality, dramatically lower price. The $13,000+ difference between us and competitors isn’t about quality. It’s about margin.
Conditions We Treat with MSC Therapy
MSC therapy’s anti-inflammatory and immunomodulatory properties make it relevant for a wide range of musculoskeletal and inflammatory conditions.
Joint Pain
Knees, hips, shoulders — MSCs target the chronic inflammation driving joint pain and degeneration.
Learn more →Osteoarthritis
Calm cartilage inflammation and support the body’s repair mechanisms without surgery or lifetime medication.
Learn more →Back Pain
Disc degeneration, spinal inflammation, chronic lower back pain — MSC therapy addresses the inflammatory root.
Learn more →Rotator Cuff Injuries
Partial tears and chronic rotator cuff inflammation respond to MSC therapy’s tissue-support properties.
Learn more →Meniscus Tears
Preserve your knee’s natural cushioning. MSC therapy may help avoid surgical meniscectomy.
Learn more →Neck Pain
Cervical disc degeneration, chronic neck stiffness, and radiculopathy driven by spinal inflammation.
Learn more →Tendonitis
Chronic tendon inflammation — Achilles, elbow, shoulder — that won’t resolve on its own.
Learn more →Bursitis
Chronically inflamed bursae in shoulders, hips, and knees that don’t respond to conservative treatment.
Learn more →Wellness & Longevity
Reduce systemic inflammation and support long-term vitality — many patients return every 6 months as a wellness protocol.
Learn more →The Clinical Evidence for MSC Therapy
A selection of significant publications and meta-analyses in MSC research.
A Note on Evidence: MSC therapy is supported by substantial preclinical data and a growing body of clinical trial evidence. However, it is not yet FDA-approved for treating specific diseases. We present the research honestly and help patients understand both the promise and limitations of current evidence during their consultation.
Same MSCs. Fraction of the Price.
Why do other clinics charge $10,000–$25,000 for the same cells? Luxury overhead, broker markups, and commissioned salespeople. We skip all of that.
MSC Stem Cell Therapy FAQ
Ready to Learn If MSC Therapy Is Right for You?
Schedule a free consultation with our team. We’ll discuss your situation honestly, explain the science, and help you determine if MSC therapy makes sense — at a price that makes sense too.
Related Resources
Premium MSC Stem Cells at a Fair Price
40 million U.S.-sourced umbilical cord MSCs. Physician-guided. Lab-verified. $1,999 all-inclusive — because quality regenerative medicine shouldn’t require a second mortgage.
Disclaimer: Stem cell therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. MSC therapy remains investigational. All clinical references on this page are based on published, peer-reviewed research. This content is provided for educational purposes only and does not constitute medical advice. Individual results vary. A consultation with our medical team is required to determine treatment appropriateness.
MSC Stem Cells:
The Complete Guide
Mesenchymal stem cells are the most widely studied cell type in regenerative medicine — backed by thousands of clinical trials worldwide. We deliver 40 million premium umbilical cord MSCs for $1,999. Here’s why that matters.
In This Guide
Mesenchymal stem cells — commonly called MSCs — are the workhorse of modern regenerative medicine. First isolated from bone marrow in the 1970s, they’ve since become the most widely studied stem cell type in human clinical trials, with over 1,700 registered studies on ClinicalTrials.gov.
What makes MSCs valuable isn’t just what they become — it’s what they do. MSCs secrete a powerful cocktail of anti-inflammatory cytokines, growth factors, and signaling molecules that can modulate the immune system, reduce chronic inflammation, and support tissue repair. This paracrine activity is now considered their primary therapeutic mechanism.
What Are Mesenchymal Stem Cells?
MSCs are multipotent adult stem cells — meaning they can differentiate into several related cell types, including bone (osteocytes), cartilage (chondrocytes), fat (adipocytes), and muscle cells. They were first described by Alexander Friedenstein in the 1970s and formally named by Arnold Caplan in 1991.
The International Society for Cellular Therapy (ISCT) defines MSCs by three minimum criteria: they must adhere to plastic in standard culture conditions, express specific surface markers (CD73, CD90, CD105) while lacking others (CD45, CD34, CD14, CD11b, CD79α, CD19, HLA-DR), and demonstrate the ability to differentiate into osteoblasts, adipocytes, and chondroblasts in vitro.
But in clinical practice, the most important thing MSCs do isn’t differentiate — it’s communicate. Through paracrine signaling, MSCs release hundreds of bioactive molecules that suppress inflammation, recruit local repair cells, inhibit cell death, promote new blood vessel formation, and modulate immune responses. This is why a single IV infusion can have systemic effects across multiple organ systems.
Key Insight: While MSCs can become bone, cartilage, and fat cells, their primary therapeutic value comes from paracrine signaling — the release of anti-inflammatory cytokines, growth factors, and extracellular vesicles that modulate immune function and support tissue repair throughout the body. Think of them less as replacement parts and more as biological repair coordinators.
Where MSCs Come From
MSCs exist naturally throughout the human body. They can be harvested from multiple tissue sources, each with distinct advantages and limitations:
Bone Marrow — The original source. Harvested via aspiration from the iliac crest (hip bone). Well-studied, but the procedure is invasive and painful. MSC quantity and quality decline significantly with age — a 60-year-old’s bone marrow contains a fraction of the MSCs found in a 20-year-old’s.
Adipose (Fat) Tissue — Harvested via liposuction. Abundant source, but MSCs have higher donor variability and require more processing. Fat-derived MSCs have a different cytokine profile than bone marrow or umbilical cord MSCs.
Umbilical Cord Tissue (Wharton’s Jelly) — Harvested from donated umbilical cord tissue after healthy births. These are the youngest, most potent MSCs available — with the longest telomeres, highest proliferative capacity, and strongest immunomodulatory properties. No invasive harvest procedure is required for the patient. This is what we use.
Peripheral Blood, Dental Pulp, Placenta — Additional sources under research, but less established for clinical therapy.
Why Source Matters: The tissue source determines everything — cell potency, proliferative capacity, immunomodulatory strength, and patient safety. Younger cells perform better. Umbilical cord MSCs are harvested at birth, making them the youngest and most biologically active source available for allogeneic (donor-based) therapy.
How MSC Therapy Works
MSCs operate through four primary mechanisms that work together to reduce inflammation and support repair.
Anti-Inflammatory Signaling
MSCs secrete anti-inflammatory cytokines (IL-10, TGF-β, PGE2) that suppress chronic inflammatory pathways. This is their most well-documented therapeutic mechanism — reducing the chronic inflammation that drives joint degeneration, back pain, and systemic conditions.
Immunomodulation
MSCs regulate both innate and adaptive immune responses — suppressing overactive T-cells, promoting regulatory T-cells, and shifting macrophages from pro-inflammatory (M1) to anti-inflammatory (M2) states. This makes them relevant for autoimmune conditions and chronic inflammatory diseases.
Trophic Support
Through growth factors (VEGF, HGF, IGF-1, bFGF), MSCs promote new blood vessel formation (angiogenesis), stimulate local progenitor cells, and inhibit cell death (apoptosis). They create a regenerative microenvironment that supports the body’s own healing processes.
Extracellular Vesicle Secretion
MSCs release exosomes and microvesicles packed with proteins, lipids, and microRNA that influence nearby cells. Research increasingly suggests that these vesicles — not the MSCs themselves — may mediate many of the observed therapeutic effects, extending the cells’ influence far beyond their immediate location.
Why We Use Umbilical Cord MSCs
Not all MSCs are equal. The tissue source dramatically affects potency, safety, and therapeutic outcomes.
We use MSCs derived from Wharton’s Jelly — the connective tissue matrix within the human umbilical cord. Here’s why this matters:
Youngest available cells. Harvested at birth, umbilical cord MSCs have the longest telomeres and highest proliferative capacity of any MSC source. Bone marrow MSCs from a 50-year-old have been through decades of cellular aging — umbilical cord MSCs haven’t.
Strongest immunomodulatory profile. UC-MSCs express low levels of HLA class II antigens and high levels of immunosuppressive factors, making them less likely to trigger immune rejection than bone marrow or adipose MSCs. This enables safe allogeneic (donor-based) therapy.
No invasive harvest. The patient doesn’t undergo bone marrow aspiration (painful hip drilling) or liposuction. Umbilical cord tissue is collected after healthy births from consenting donors — a process that’s painless for both mother and child.
Consistent quality. Bone marrow and adipose MSC quality varies enormously based on the patient’s age, health, and genetics. Umbilical cord MSCs from screened, healthy donors provide a consistent, high-potency product every time.
Ethically uncontroversial. Umbilical cord tissue is typically discarded after birth. Using it for stem cell therapy gives this tissue a second purpose with no ethical concerns.
MSC Source Comparison
How umbilical cord MSCs compare to bone marrow and adipose-derived alternatives.
| Feature | Bone Marrow MSCs | Adipose MSCs | Umbilical Cord MSCs |
|---|---|---|---|
| Cell Age | Patient’s age (older) | Patient’s age (older) | ✔ Neonatal (youngest) |
| Proliferative Capacity | Moderate — declines with age | Moderate | Highest — longest telomeres |
| Immunomodulatory Strength | Moderate | Moderate | Strong — low HLA-II, high suppression |
| Harvest Method | Invasive — iliac crest aspiration | Invasive — liposuction | Non-invasive — donated tissue |
| Donor Variability | High — age/health dependent | High — variable quality | Low — screened, consistent |
| Immune Rejection Risk | Low (autologous) | Low (autologous) | Low — immunoprivileged |
| Ethical Concerns | None | None | None — otherwise discarded |
| Clinical Evidence | Extensive | Moderate | Extensive and growing |
What You’re Getting at The Stem Cell Club
Not all clinics are transparent about what’s in their stem cell product. We are.
U.S.-Sourced Only
100% American umbilical cord tissue from FDA-registered labs. No offshore labs, no unknown supply chains.
Screened Donors
Carefully screened donor mothers with full medical history review. Non-vaccinated donors per patient preference.
Lab-Verified Potency
Third-party testing confirms cell count and viability before treatment. You know exactly what you’re receiving.
FDA Compliant
Minimally manipulated per all FDA guidelines for human cells, tissues, and cellular and tissue-based products (HCT/P).
Proper Cold Chain
Cryo-preserved at optimal temperature. Temperature monitored throughout the entire supply chain from lab to clinic.
Physician-Administered
Andrea Montana, MSN, APRN oversees every treatment. No unsupervised techs. No rushed procedures.
Why We Source Direct: Many stem cell clinics buy from brokers who buy from labs — each adding a markup. We source directly from FDA-registered laboratories, eliminating middleman costs. Same cells, same quality, dramatically lower price. The $13,000+ difference between us and competitors isn’t about quality. It’s about margin.
Conditions We Treat with MSC Therapy
MSC therapy’s anti-inflammatory and immunomodulatory properties make it relevant for a wide range of musculoskeletal and inflammatory conditions.
Joint Pain
Knees, hips, shoulders — MSCs target the chronic inflammation driving joint pain and degeneration.
Learn more →Osteoarthritis
Calm cartilage inflammation and support the body’s repair mechanisms without surgery or lifetime medication.
Learn more →Back Pain
Disc degeneration, spinal inflammation, chronic lower back pain — MSC therapy addresses the inflammatory root.
Learn more →Rotator Cuff Injuries
Partial tears and chronic rotator cuff inflammation respond to MSC therapy’s tissue-support properties.
Learn more →Meniscus Tears
Preserve your knee’s natural cushioning. MSC therapy may help avoid surgical meniscectomy.
Learn more →Neck Pain
Cervical disc degeneration, chronic neck stiffness, and radiculopathy driven by spinal inflammation.
Learn more →Tendonitis
Chronic tendon inflammation — Achilles, elbow, shoulder — that won’t resolve on its own.
Learn more →Bursitis
Chronically inflamed bursae in shoulders, hips, and knees that don’t respond to conservative treatment.
Learn more →Wellness & Longevity
Reduce systemic inflammation and support long-term vitality — many patients return every 6 months as a wellness protocol.
Learn more →The Clinical Evidence for MSC Therapy
A selection of significant publications and meta-analyses in MSC research.
A Note on Evidence: MSC therapy is supported by substantial preclinical data and a growing body of clinical trial evidence. However, it is not yet FDA-approved for treating specific diseases. We present the research honestly and help patients understand both the promise and limitations of current evidence during their consultation.
Same MSCs. Fraction of the Price.
Why do other clinics charge $10,000–$25,000 for the same cells? Luxury overhead, broker markups, and commissioned salespeople. We skip all of that.
MSC Stem Cell Therapy FAQ
Ready to Learn If MSC Therapy Is Right for You?
Schedule a free consultation with our team. We’ll discuss your situation honestly, explain the science, and help you determine if MSC therapy makes sense — at a price that makes sense too.
Related Resources
Premium MSC Stem Cells at a Fair Price
40 million U.S.-sourced umbilical cord MSCs. Physician-guided. Lab-verified. $1,999 all-inclusive — because quality regenerative medicine shouldn’t require a second mortgage.
Disclaimer: Stem cell therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. MSC therapy remains investigational. All clinical references on this page are based on published, peer-reviewed research. This content is provided for educational purposes only and does not constitute medical advice. Individual results vary. A consultation with our medical team is required to determine treatment appropriateness.
ACL Injury Stem Cell
Therapy — $1,999
Partial ACL tears, ACL sprains, chronic ACL deficiency, post-surgical recovery — MSC stem cell therapy helps reduce knee inflammation and support ligament healing. Not $15,000. No sales games.
ACL Reconstruction Isn’t Your Only Option
When you hear “torn ACL,” the assumption is surgery. But here’s what many patients don’t realize: ACL reconstruction means harvesting a tendon graft from elsewhere in your body (or a donor), drilling tunnels through your bones, and 6–12 months of grueling rehab — with no guarantee you’ll return to your previous level.
For partial tears, lower-demand patients, and those looking to support post-surgical recovery, stem cell therapy offers a different path — reducing inflammation and supporting your body’s healing process without the operating room.
ACL Injuries That May Benefit From Stem Cell Therapy
Not every ACL injury needs reconstruction. Here’s an honest look at who may benefit most — and who may still need surgery.
Partial ACL Tears (Grade I–II)
Your ACL is stretched or partially torn but still has structural continuity. These are strong candidates for stem cell therapy — the ligament has intact tissue to support and an environment worth improving.
Non-Surgical ACL Management
Some patients with complete ACL tears function well without surgery — especially those who don’t play cutting/pivoting sports. MSC therapy can support knee health, reduce inflammation, and protect surrounding cartilage.
Post-ACL Reconstruction Support
Had your ACL reconstructed? MSCs can support graft healing, reduce post-surgical inflammation, and address secondary damage to cartilage and meniscus that often accompanies ACL injuries.
Chronic ACL Deficiency
Living with an old ACL tear that’s causing ongoing knee pain, swelling, and instability? Even years after injury, MSCs can help reduce the chronic inflammation accelerating joint deterioration.
Older Adults & Lower-Demand Patients
If you’re not returning to competitive pivoting sports, reconstruction may be more invasive than necessary. MSC therapy can improve knee function for hiking, cycling, swimming, gym workouts, and daily life.
ACL + Meniscus / Cartilage Damage
ACL tears rarely happen alone — meniscus tears, cartilage damage, and bone bruises often accompany them. MSC therapy addresses the entire knee environment, not just one structure.
An Honest Note About Complete ACL Tears
We believe in transparency. If you’re a young, competitive athlete with a complete ACL tear who needs to return to cutting and pivoting sports (soccer, basketball, skiing), ACL reconstruction is still the standard of care. We’ll tell you that during your consultation — we’d rather refer you to a great surgeon than oversell what stem cells can do.
What Stem Cells Do Inside Your Injured Knee
MSCs are repair coordinators — they improve the environment inside your knee so your body can support its own healing process.
Reduce Acute & Chronic Inflammation
ACL injuries trigger massive inflammation that damages surrounding cartilage and meniscus. MSCs release powerful anti-inflammatory molecules that calm this environment — protecting the rest of your knee.
Support Ligament Healing
MSCs release growth factors and signaling molecules that support collagen production and tissue repair — particularly beneficial for partial tears where the ligament still has structural continuity to build on.
Protect Surrounding Structures
ACL injuries accelerate damage to cartilage and meniscus. MSCs create a protective environment that may slow this cascade — reducing the risk of developing arthritis years after injury.
Enhance Blood Supply
The ACL has notoriously poor blood supply — a key reason it heals slowly. MSCs promote angiogenesis, improving blood flow and nutrient delivery to the damaged ligament.
Reduce Pain & Swelling
As inflammation calms and the knee environment improves, pain and swelling decrease naturally. Many patients regain range of motion and function faster than with conservative treatment alone.
Support Graft Healing (Post-Surgery)
For patients who’ve had reconstruction, MSCs can support graft integration, reduce post-surgical inflammation, and help address the secondary damage that surgery doesn’t fix.
ACL Treatment Without the Markup
Other clinics charge $15,000+ and won’t tell you until after a sales consultation. We believe you deserve to know upfront.
4 Simple Steps
Free Consultation
Phone or Zoom with our team (15 minutes). Discuss your ACL injury, MRI findings, activity level, and goals. We’ll be honest about whether stem cells or surgery is the better path for your specific situation.
Treatment Plan
Andrea Montana, MSN, APRN reviews your case and MRI. She’ll recommend targeted knee injection (most common for ACL injuries) and discuss realistic expectations based on your tear grade and activity goals.
Treatment Day
1–2 hours in our comfortable St. George clinic. 40 million premium MSCs delivered via direct knee injection for maximum concentration at the injury site. Full physician oversight. Go home same day — walking.
Results Over Time
Weeks 2–4: Reduced swelling and pain, improved range of motion. Months 2–6: Progressive improvement in stability and function. We recommend physical therapy alongside treatment to maximize results.
Common Questions About ACL Treatment
Find Out If Stem Cells Can Help Your ACL Injury
Tell us about your knee and we’ll give you an honest assessment — including whether surgery might be the better option for your specific injury and goals.
- ✓ Free 15-minute phone or Zoom consultation
- ✓ We’ll review your MRI findings
- ✓ Honest about when surgery is better
- ✓ Know the exact price upfront: $1,999
- ✓ Speak directly with our medical team
Explore Your Options Before the Operating Room
Schedule a free consultation. We’ll review your MRI and tell you honestly whether stem cell therapy makes sense for your ACL injury — or whether surgery is the smarter path.
Stem cell therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. Individual results vary. The information on this page is for educational purposes only and does not constitute medical advice. A consultation with our medical team is required to determine treatment appropriateness.
Meniscus Tear Stem Cell
Therapy — $1,999
Torn meniscus, degenerative meniscus, knee cartilage damage — MSC stem cell therapy helps reduce knee inflammation and support healing without surgery. Keep your meniscus. Not $15,000. No sales games.
Why Meniscus Surgery Isn’t Always the Answer
Here’s what most surgeons won’t tell you: meniscus surgery — especially partial meniscectomy — removes the very cushioning your knee depends on. Studies show many patients develop accelerated arthritis within years of meniscus surgery because there’s less tissue protecting the joint.
Stem cell therapy takes a different approach — preserving your meniscus tissue while reducing the inflammation and supporting the healing environment inside your knee.
Stem Cell Therapy for Meniscus Injuries
Not all meniscus tears are created equal. Your tear type, location, and severity determine how well stem cell therapy can help — and we’ll be honest about your specific situation.
Degenerative Meniscus Tears
The most common type in adults over 40. Your meniscus wears down over time and develops tears from normal activity — not a single injury. Often responds well to MSC therapy because the root cause is chronic degeneration.
Partial Tears
The meniscus is torn but not completely through. These tears often cause intermittent pain, catching, and swelling. Strong candidates for stem cell therapy because there’s intact tissue to work with.
Acute Traumatic Tears
Sudden tears from sports, twisting, or impact. Common in athletes and active adults. Tears in the outer third (red zone) have better blood supply and may benefit more from MSC therapy.
Horizontal Cleavage Tears
The meniscus splits horizontally along its layers. Common in older adults with degenerative changes. Often not repairable surgically, making non-surgical approaches particularly valuable.
Medial Meniscus Tears
The inner meniscus — tears here are 5x more common than lateral side. Pain on the inner knee, worse with twisting or squatting. The most frequently treated meniscus location.
Post-Surgical Meniscus Pain
Had meniscus surgery but still have knee pain? Common — especially after partial meniscectomy. MSCs can help reduce the inflammation and joint deterioration that often follows meniscus removal.
What Stem Cells Do Inside Your Damaged Knee
MSCs are repair coordinators — they improve the environment inside your knee so your body can support its own healing process.
Reduce Knee Inflammation
A torn meniscus creates chronic inflammation inside the joint. MSCs release powerful anti-inflammatory molecules that calm this environment — reducing swelling, pain, and the ongoing damage inflammation causes.
Protect Remaining Cartilage
Once a meniscus is damaged, the surrounding cartilage is at risk. MSCs create a protective environment that may slow further degeneration — helping prevent the cascade toward arthritis.
Support Tissue Repair Signaling
MSCs release growth factors and signaling molecules that recruit your body’s own repair cells to the damaged area. For tears in the vascularized outer zone, this can meaningfully support the healing process.
Improve Synovial Fluid Quality
Better joint fluid means better lubrication, less friction, and smoother movement. MSCs help improve synovial fluid quality — which alone can significantly reduce pain and improve function.
Reduce Pain Naturally
As inflammation calms and the knee environment improves, pain signals decrease naturally. Many patients reduce or eliminate pain medications and return to activities they’d given up.
Preserve Your Meniscus
Unlike surgery that removes damaged tissue, stem cell therapy preserves what you have. Every bit of meniscus you keep protects your knee from accelerated arthritis down the road.
Meniscus Treatment Without the Markup
Other clinics charge $15,000+ and won’t tell you until after a sales consultation. We believe you deserve to know upfront.
4 Simple Steps
Free Consultation
Phone or Zoom with our team (15 minutes). Discuss your meniscus tear, MRI findings, symptoms, previous treatments, and goals. If we can’t help — or if you need surgery instead — we’ll tell you honestly.
Treatment Plan
Andrea Montana, MSN, APRN reviews your case and MRI. She’ll recommend targeted knee injection (most common for meniscus tears) or IV therapy if you have additional joint issues. Honest assessment of what to expect.
Treatment Day
1–2 hours in our comfortable St. George clinic. 40 million premium MSCs delivered via direct knee injection for maximum local concentration. Full physician oversight. Most patients find it straightforward. Go home same day.
Results Over Time
Weeks 2–4: Reduced pain and swelling, improved range of motion. Months 2–6: Continued improvement as the knee environment heals. Many patients return to full activity within 2–3 months — far faster than surgical recovery.
Common Questions About Meniscus Treatment
Find Out If Stem Cells Can Help Your Meniscus Tear
Tell us about your knee and we’ll give you an honest assessment — including whether surgery might be the better option for your specific tear.
- ✓ Free 15-minute phone or Zoom consultation
- ✓ We’ll review your MRI findings
- ✓ No sales pressure — we’ll tell you if surgery is better
- ✓ Know the exact price upfront: $1,999
- ✓ Speak directly with our medical team
Learn More
Keep Your Meniscus. Skip the Surgery.
Schedule a free consultation. We’ll review your MRI and tell you honestly whether stem cell therapy can help your specific meniscus tear — no pressure, no obligation.
Stem cell therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. Individual results vary. The information on this page is for educational purposes only and does not constitute medical advice. A consultation with our medical team is required to determine treatment appropriateness.
Bursitis Stem Cell
Therapy — $1,999
Hip, shoulder, knee, elbow bursitis — MSC stem cell therapy helps reduce chronic bursa inflammation and break the cycle of flare-ups without repeated cortisone. Not $15,000. No sales games.
Why Traditional Bursitis Treatments Fall Short
Bursitis isn’t just temporary inflammation — when bursae become chronically irritated, they thicken, scar, and lose their ability to cushion your joints. The result is a painful cycle of flare-ups that gets harder to break with each episode.
Stem cell therapy takes a different approach — calming the chronic inflammatory environment inside and around the bursa rather than temporarily suppressing symptoms.
Stem Cell Therapy for Every Type of Bursitis
Your body has over 150 bursae — small fluid-filled sacs that cushion joints. When they become chronically inflamed, MSCs help calm the environment and support healing.
Hip Bursitis (Trochanteric)
The most common type. Sharp pain on the outer hip that worsens lying on your side, climbing stairs, or standing from sitting. Affects millions — especially women over 40.
Shoulder Bursitis (Subacromial)
Pain with overhead reaching, difficulty sleeping on the affected side, catching or clicking sensations. Often occurs alongside rotator cuff issues, compounding the problem.
Knee Bursitis (Prepatellar)
Swelling and tenderness at the front of the knee. Common in people who kneel frequently — construction workers, gardeners, flooring installers. Also called “housemaid’s knee.”
Elbow Bursitis (Olecranon)
Visible swelling at the tip of the elbow, sometimes called “student’s elbow.” Pain with bending, leaning on hard surfaces, or direct pressure. Can become chronic and recurrent.
Ischial Bursitis (Sit Bone)
Deep pain in the buttock that worsens with sitting — especially on hard surfaces. Often misdiagnosed as sciatica or hamstring injury. Makes desk work and driving miserable.
Heel Bursitis (Retrocalcaneal)
Pain at the back of the heel where the Achilles tendon meets the bone. Worsens with shoes and activity. Often accompanies Achilles tendonitis, creating a double problem.
What Stem Cells Do Inside Inflamed Bursae
MSCs are repair coordinators — they modulate the inflammatory environment and signal your body to heal rather than continue the damage cycle.
Calm Chronic Inflammation
MSCs release powerful anti-inflammatory molecules that break the chronic inflammation cycle trapping your bursa in a state of constant irritation — addressing the root cause, not just symptoms.
Modulate Immune Response
Chronic bursitis involves an overactive local immune response. MSCs help recalibrate immune activity in the affected area, reducing the excessive inflammatory signals damaging tissue.
Support Tissue Repair
MSCs release growth factors and signaling molecules that help repair the thickened, scarred bursa lining — working to restore normal cushioning function over time.
Improve Local Blood Flow
Better circulation means faster delivery of nutrients and removal of inflammatory waste products. MSCs promote healthier vascularity around the damaged bursa.
Reduce Pain Naturally
As inflammation calms and the bursa environment improves, pain signals decrease naturally. Many patients reduce or eliminate pain medications and cortisone dependence.
Break the Flare-Up Cycle
Rather than chasing each flare-up with cortisone, MSCs help address the underlying dysfunction — giving many patients longer-lasting relief and fewer recurrences.
Bursitis Treatment Without the Markup
Other clinics charge $15,000+ and won’t tell you until after a sales consultation. We believe you deserve to know upfront.
4 Simple Steps
Free Consultation
Phone or Zoom with our team (15 minutes). Discuss your bursitis location, frequency of flare-ups, previous treatments, and goals. If we can’t help, we’ll tell you honestly.
Treatment Plan
Andrea Montana, MSN, APRN reviews your case. She’ll recommend IV therapy (best for multiple affected areas or systemic inflammation) or targeted injection (best for a single bursa like hip or shoulder).
Treatment Day
1–2 hours in our comfortable St. George clinic. 40 million premium MSCs delivered via IV or direct injection near the affected bursa. Full physician oversight. Most patients find it relaxing. Go home same day.
Results Over Time
Weeks 2–4: Reduced pain, less swelling, improved range of motion. Months 2–6: Continued improvement as the inflammatory environment calms. Many patients experience significantly fewer flare-ups for 6–12+ months.
Common Questions About Bursitis Treatment
Find Out If Stem Cells Can Help Your Bursitis
Tell us about your bursitis and we’ll give you an honest assessment. 15 minutes, no pressure.
- ✓ Free 15-minute phone or Zoom consultation
- ✓ Discuss your specific situation honestly
- ✓ No sales pressure — we’ll tell you if we can’t help
- ✓ Know the exact price upfront: $1,999
- ✓ Speak directly with our medical team
Learn More
Stop Living Around Your Bursitis
Schedule a free consultation. We’ll tell you honestly whether stem cell therapy can help your specific bursitis — no pressure, no obligation.
Stem cell therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. Individual results vary. The information on this page is for educational purposes only and does not constitute medical advice. A consultation with our medical team is required to determine treatment appropriateness.
Tendonitis Stem Cell
Therapy — $1,999
Achilles, rotator cuff, tennis elbow, patellar tendonitis — MSC stem cell therapy helps reduce chronic tendon inflammation and support tissue repair without surgery. Not $15,000. No sales games.
Why Traditional Tendonitis Treatments Fall Short
Tendonitis isn’t just inflammation — it’s chronic tendon degeneration. When tendons don’t heal properly, the tissue breaks down, weakens, and becomes a cycle of pain and re-injury. Most treatments only manage the pain while the tendon continues to deteriorate underneath.
Stem cell therapy takes a different approach — addressing the damaged tendon environment and supporting the repair process rather than just masking pain.
Stem Cell Therapy for Every Type of Tendonitis
Whether it’s overuse, age-related, or sports-driven — MSCs address the chronic inflammation and tissue breakdown that drive all forms of tendinopathy.
Achilles Tendonitis
Pain, stiffness, and swelling at the back of the ankle. Common in runners and active adults. Chronic cases can lead to tendon rupture if left unaddressed.
Rotator Cuff Tendinopathy
Shoulder pain with overhead movements, night pain, weakness. Partial tears and chronic inflammation that physical therapy alone can’t resolve.
Tennis Elbow (Lateral Epicondylitis)
Outer elbow pain that radiates into the forearm. Gripping, lifting, and twisting become painful. Affects athletes and desk workers alike.
Golfer’s Elbow (Medial Epicondylitis)
Inner elbow pain and tenderness. Common in golfers, climbers, and anyone with repetitive wrist and forearm motions. Often resistant to conservative treatment.
Patellar Tendonitis (Jumper’s Knee)
Pain below the kneecap that worsens with jumping, running, and stairs. Common in basketball, volleyball, and running. Can become chronic without proper intervention.
Plantar Fasciitis
Stabbing heel pain worst with first morning steps. Chronic inflammation of the plantar fascia — a thick band of tissue connecting heel to toes. Affects 2 million Americans yearly.
What Stem Cells Do Inside Damaged Tendons
MSCs are repair coordinators — they create an environment that supports your body’s natural tendon healing process.
Reduce Chronic Inflammation
MSCs release powerful anti-inflammatory molecules that calm the chronic inflammation cycle trapping your tendon in a state of degeneration — addressing the root cause, not just symptoms.
Support Tissue Repair Signaling
MSCs release growth factors and signaling molecules (the secretome) that recruit your body’s own repair cells to the damaged tendon — essentially calling in reinforcements.
Improve Collagen Organization
Healthy tendons need organized collagen fibers. MSCs help improve the quality and alignment of new collagen production, supporting stronger, more functional tendon tissue.
Enhance Blood Supply
Many tendons have poor blood flow — a key reason they heal slowly. MSCs promote angiogenesis (new blood vessel formation), improving nutrient delivery to damaged tissue.
Reduce Pain Naturally
As inflammation decreases and the tendon environment improves, pain signals decrease naturally. Many patients reduce or eliminate pain medications over time.
Delay or Avoid Surgery
For many tendonitis patients, stem cell therapy provides enough relief and functional improvement to delay or completely avoid tendon surgery — saving months of recovery.
Tendonitis Treatment Without the Markup
Other clinics charge $15,000+ and won’t tell you until after a sales consultation. We believe you deserve to know upfront.
4 Simple Steps
Free Consultation
Phone or Zoom with our team (15 minutes). Discuss your tendon condition, location, severity, previous treatments, and goals. If we can’t help, we’ll tell you honestly.
Treatment Plan
Andrea Montana, MSN, APRN reviews your case. She’ll recommend IV therapy (best for multiple tendons or systemic inflammation) or targeted injection (best for a single tendon like Achilles or rotator cuff).
Treatment Day
1–2 hours in our comfortable St. George clinic. 40 million premium MSCs delivered via IV or direct tendon injection. Full physician oversight. Most patients find it relaxing. Go home same day.
Results Over Time
Weeks 2–4: Reduced pain, less stiffness, improved function. Months 2–6: Continued improvement as tendon tissue repair progresses. Many patients return to full activity within 3–6 months.
Common Questions About Tendonitis Treatment
Find Out If Stem Cells Can Help Your Tendonitis
Tell us about your tendon condition and we’ll give you an honest assessment. 15 minutes, no pressure.
- ✓ Free 15-minute phone or Zoom consultation
- ✓ Discuss your specific situation honestly
- ✓ No sales pressure — we’ll tell you if we can’t help
- ✓ Know the exact price upfront: $1,999
- ✓ Speak directly with our medical team
Learn More
Don’t Let Tendonitis Sideline Your Life
Schedule a free consultation. We’ll tell you honestly whether stem cell therapy can help your specific tendon condition — no pressure, no obligation.
Stem cell therapy is not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. Individual results vary. The information on this page is for educational purposes only and does not constitute medical advice. A consultation with our medical team is required to determine treatment appropriateness.